Search

Neil J Poloso

from Lake Forest, CA
Age ~49
Get Report
Also known as:
Neil John Poloso, Neil Pulos, Neil O
Phone and address:
25541 Loganberry Ln, El Toro, CA 92630
Related to:
Toni Salter, 47Nathan Hughes, 59Thomas S Salter, 46Maryann E Gilmartin, 80Jerry N Gilmartin, 90R OYolanda Poloso, 74Kristopher S Gilmartin, 47Anthony Poloso, 74Masumi L Hughes, 51Timothy Gilmartin, 45Robin E Gilmartin, 52
Connected to:
Duncan L Polot, 33Alexander Polotsk, 68Stacey Polott, 39Victor Polotto, 41Gaby Polous, 67Alexander Y Polovets, 68Pauline Polovets, 72Alexis Polovina, 41Anna A Polovin, 48Jeffrey J Polovina, 76

Neil Poloso Phones & Addresses

  • 25541 Loganberry Ln, Lake Forest, CA 92630
  • El Toro, CA
  • 2801 Main St #348, Irvine, CA 92614 (949) 379-6361
  • 1619 Farragut Ave, Rockville, MD 20851 (301) 762-3996
  • Gaithersburg, MD
  • Odenton, MD
  • Prairieville, LA
  • Atlanta, GA
  • Orange, CA
  • Aliso Viejo, CA

Work

Company: Abbvie May 2020 Position: Executive director, biological research at allergan aesthetics, an abbvie company

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Emory University 1997 to 2002 Specialities: Immunology

Skills

Immunology • Molecular Biology • Assay Development • Cell Culture • Pharmaceutical Industry • Cell Biology • Drug Discovery • Elisa • Drug Development • Flow Cytometry • Pcr • Cell • In Vivo • Protein Chemistry • Biology • Western Blotting • Pharmacology • Confocal Microscopy • Oncology • Immunoassays • Transfection • Tissue Culture • Rt Pcr • Qpcr • In Vitro • Molecular Cloning • Microscopy • Obesity • Animal Models • Rna Isolation • Facs • Inflammation • Science

Languages

English

Industries

Pharmaceuticals

Resumes

Resumes

Neil Poloso Photo 1

Executive Director, Biological Research At Allergan Aesthetics, An Abbvie Company

View page
Location:
25541 Loganberry Ln, Lake Forest, CA 92630
Industry:
Pharmaceuticals
Work:
Abbvie
Executive Director, Biological Research at Allergan Aesthetics, An Abbvie Company
Allergan Feb 2012 - Feb 2014
Principal Scientist
Allergan Feb 2012 - Feb 2014
Director, Biological Research
Allergan Feb 2010 - Feb 2012
Senior Scientist
Allergan Aug 2008 - Jan 2010
Scientist- Principal Biology
Education:
Emory University 1997 - 2002
Doctorates, Doctor of Philosophy, Immunology University of Delaware 1993 - 1997
Bachelors, Bachelor of Science, Biotechnology, Biology
Skills:
Immunology
Molecular Biology
Assay Development
Cell Culture
Pharmaceutical Industry
Cell Biology
Drug Discovery
Elisa
Drug Development
Flow Cytometry
Pcr
Cell
In Vivo
Protein Chemistry
Biology
Western Blotting
Pharmacology
Confocal Microscopy
Oncology
Immunoassays
Transfection
Tissue Culture
Rt Pcr
Qpcr
In Vitro
Molecular Cloning
Microscopy
Obesity
Animal Models
Rna Isolation
Facs
Inflammation
Science
Languages:
English

Publications

Us Patents

Fatty Acid Amide Hydrolase Inhihibitors For Treating Pain

View page
US Patent:
20120270915, Oct 25, 2012
Filed:
Apr 23, 2012
Appl. No.:
13/453068
Inventors:
David F. Woodward - Lake Forest CA, US
Jose L. Martos - Basildon Essex, GB
William R. Carling - Bishop's Stortford, GB
Neil J. Poloso - Lake Forest CA, US
Jenny W. Wang - Irvine CA, US
International Classification:
A61K 31/422
A61P 25/00
C07D 413/04
US Classification:
514374, 548238
Abstract:
Compounds of Formula 1 are described herein. These compounds may be administered to a patient for treatment of suffering from pain or other FAAH mediated conditions.

Ester Derivatives Of Bimatoprost Compositions And Methods

View page
US Patent:
20120295972, Nov 22, 2012
Filed:
Feb 13, 2012
Appl. No.:
13/371851
Inventors:
David F. Woodward - Lake Forest CA, US
Jenny W. Wang - Irvine CA, US
Neil J. Poloso - Lake Forest CA, US
Todd Gac - Santa Ana CA, US
Robert M. Burk - Laguna Beach CA, US
Michael E. Garst - Newport Beach CA, US
International Classification:
C07C 69/18
A61Q 7/00
A61K 8/42
US Classification:
514546, 560252
Abstract:
Provided herein, inter alia, are prodrugs of bimatoprost, methods of using the same and compositions including the same.

Ester Derivatives Of Bimatoprost Compositions And Methods

View page
US Patent:
20130324606, Dec 5, 2013
Filed:
Feb 13, 2012
Appl. No.:
13/985263
Inventors:
David F. Woodward - Lake Forest CA, US
Jenny W. Wang - Irvine CA, US
Neil J. Poloso - Lake Forest CA, US
Todd S. Gac - Santa Ana CA, US
Robert M. Burk - Laguna Beach CA, US
Michael E. Garst - Newport Beach CA, US
Assignee:
ALLERGAN, INC. - IRVINE CA
International Classification:
C07C 405/00
US Classification:
514546, 560252
Abstract:
Provided herein, inter alia, are prodrugs of bimatoprost, methods of using the same and compositions including the same.

Inhibition Of Gliadin Peptides

View page
US Patent:
20110275562, Nov 10, 2011
Filed:
May 6, 2009
Appl. No.:
12/991658
Inventors:
Sefik Alkan - Baltimore MD, US
Amir Tamiz - Silver Spring MD, US
Kelly Marie Kitchens - Laurel MD, US
Malarvizhi Durai - Ellicott City MD, US
Neil Poloso - Rockville MD, US
Rosa A. Carrasco - Baltimore MD, US
International Classification:
A61K 38/08
C07K 5/09
C07K 5/103
C07K 5/083
C07K 5/097
A61P 3/00
C07K 5/093
A61K 38/06
A61K 38/07
A61P 3/10
A61P 17/00
C07K 7/06
C07K 5/087
US Classification:
514 69, 530328, 530329, 530330, 530331, 514 217, 514 216, 514 218, 514 219, 514 186
Abstract:
Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided. Methods for treating diseases relating to aberrant biological barrier permeability and peptide translocation across biological barriers are provided. Such diseases include celiac disease, necrotizing enterocolitis, diabetes, cancer, inflammatory bowel diseases, asthma, COPD, excessive or undesirable immune response, gluten sensitivity, gluten allergy, food allergy, rheumatoid arthritis, multiple sclerosis, immune-mediated or type 1 diabetes mellitus, systemic lupus erythematosus, psoriasis, scleroderma and autoimmune thyroid diseases.

Inhibition Of Gliadin Peptides

View page
US Patent:
20200231626, Jul 23, 2020
Filed:
Nov 22, 2019
Appl. No.:
16/692640
Inventors:
- Baltimore MD, US
Amir Tamiz - Silver Spring MD, US
Kelly Marie Kitchens - Laurel MD, US
Malarvizhi Durai - Ellicott City MD, US
Neil Poloso - Rockville MD, US
Rosa A. Carrasco - Baltimore MD, US
International Classification:
C07K 7/06
A61K 45/06
C07K 5/083
C07K 5/087
C07K 5/09
C07K 5/093
C07K 5/097
C07K 5/103
A61K 38/06
A61K 38/07
A61K 38/08
Abstract:
Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided. Methods for treating diseases relating to aberrant biological barrier permeability and peptide translocation across biological barriers are provided. Such diseases include celiac disease, necrotizing enterocolitis, diabetes, cancer, inflammatory bowel diseases, asthma, COPD, excessive or undesirable immune response, gluten sensitivity, gluten allergy, food allergy, rheumatoid arthritis, multiple sclerosis, immune-mediated or type 1 diabetes mellitus, systemic lupus erythematosus, psoriasis, scleroderma and autoimmune thyroid diseases.

Prostacyclin Receptor Agonists For Reduction Of Body Fat

View page
US Patent:
20200171026, Jun 4, 2020
Filed:
Jul 27, 2018
Appl. No.:
16/634532
Inventors:
- Irvine CA, US
Neil J. Poloso - Lake Forest CA, US
John E. Donello - Dana Point CA, US
Qianyong Liu - Tustin CA, US
International Classification:
A61K 31/4965
A61K 31/27
A61K 31/343
A61K 31/191
A61P 3/04
Abstract:
Prostacyclin (PGI2) analogues which are agonists of the prostacyclin receptor (PI) are demonstrated to activate lipolytic activity in adipocytes. Also described are pharmaceutical compositions and methods for using the PGI2 receptor agonists to reduce subcutaneous adipose tissue and to treat or reduce symptoms of obesity-related diseases or disorders such as diabetes mellitus, fatty liver disease and cardiovascular disease.

Inhibition Of Gliadin Peptides

View page
US Patent:
20180134750, May 17, 2018
Filed:
Jan 2, 2018
Appl. No.:
15/860118
Inventors:
- Baltimore MD, US
Amir Tamiz - Silver Spring MD, US
Kelly Marie Kitchens - Laurel MD, US
Malarvizhi Durai - Ellicott City MD, US
Neil Poloso - Rockville MD, US
Rosa A. Carrasco - Baltimore MD, US
International Classification:
C07K 7/06
C07K 5/103
C07K 5/097
C07K 5/093
C07K 5/09
C07K 5/087
C07K 5/083
A61K 45/06
A61K 38/08
A61K 38/07
A61K 38/06
A61K 38/00
Abstract:
Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided. Methods for treating diseases relating to aberrant biological barrier permeability and peptide translocation across biological barriers are provided. Such diseases include celiac disease, necrotizing enterocolitis, diabetes, cancer, inflammatory bowel diseases, asthma, COPD, excessive or undesirable immune response, gluten sensitivity, gluten allergy, food allergy, rheumatoid arthritis, multiple sclerosis, immune-mediated or type 1 diabetes mellitus, systemic lupus erythematosus, psoriasis, scleroderma and autoimmune thyroid diseases.

Methods Of Adipolysis And Compositions Useful Therein

View page
US Patent:
20170095447, Apr 6, 2017
Filed:
Sep 30, 2016
Appl. No.:
15/283246
Inventors:
- Calabasas CA, US
Alain Vasserot - Calabasas CA, US
Neil Poloso - Irvine CA, US
Assignee:
KYTHERA BIOPHARMACEUTICALS, INC. - Calabasas CA
International Classification:
A61K 31/405
A61K 45/06
A61K 9/00
A61K 31/366
Abstract:
Provided herein are pharmacologically active compositions suitable for topical application or injection directly for fat treatment without the need for surgical intervention.
Control profile
Neil J Poloso from Lake Forest, CA, age ~49 Get Report